| Gene symbol | tk |
| GTO ID | GTC1457 |
| Trial ID | NCT01913106 |
| Disease | Prostate Cancer |
| Altered gene | tk |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | Adv-tk |
| Co-treatment | Valacyclovir|Brachytherapy |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Phase I-II Study HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer With or Without Metastatic Disease |
| Year | 2013 |
| Country | United States |
| Company sponsor | The Methodist Hospital Research Institute |
| Other ID(s) | Pro00000601|IRB 0107-0009 |
| Vector information | |||||||||||
|
|||||||||||
| Cohort 1 | |||||||
|
|||||||